Multiple Sclerosis, Chronic Progressive  >>  Rituxan (rituximab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rituxan (rituximab) / Roche
NCT02253264: A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients

Completed
1
8
US
Rituximab, Rituxan
Johns Hopkins University
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis
08/17
08/17

Download Options